about
Natriuretic peptide type AGuanylate cyclase 2cAquaporin 1Guanylate cyclase 2CAquaporin 1Natriuretic peptide receptor 1Natriuretic peptide receptor 25-hydroxytryptamine receptor 2CGuanylate cyclase soluble subunit beta-2Guanylate cyclase 1 soluble subunit alpha 2Guanylate cyclase 1 soluble subunit alpha 1Guanylate cyclase 1 soluble subunit beta 1Adenylate cyclase 6Adenylate cyclase 3Adenylate cyclase 9Adenylate cyclase 5Adenylate cyclase 8Adenylate cyclase 7Adenylate cyclase 2Adenylate cyclase 1Adenylate cyclase 4Natriuretic peptide CGuanylate cyclase 2F, retinalGuanylate cyclase 2D, retinalGuanylate cyclase activator 2BGuanylate cyclase 2eGuanylate cyclase 2gAdenylate cyclase 1Adenylate cyclase 7Adenylate cyclase 9Adenylate cyclase 5Adenylate cyclase 8Adenylate cyclase 6Adenylate cyclase type 2Adenylate cyclase 3Adenylate cyclase 4Guanylate cyclase 1, soluble, beta 1Guanylate cyclase 1, soluble, alpha 15-hydroxytryptamine (serotonin) receptor 2C5-hydroxytryptamine (serotonin) receptor 2B
P682
Q14860793-58ABC562-6497-44D4-8DD6-D73456911632Q14860793-C22CA404-2825-4316-887D-09DE4DB779A3Q14888940-42FE4263-2251-4AB5-B52E-D303EA01A3BAQ14888940-C9115E2D-6089-48F8-BD4F-64E55A6E9B83Q14905246-5E644A65-C4B2-4E4A-913C-C0241F40CF5AQ14905246-74D7033D-B514-469C-B2FC-E0766E7D1358Q1552797-56747C66-B5DA-4367-A3F4-72B67F0965A4Q2083074-CABE6024-AE48-463B-B2B7-1DD77B8D939FQ21105144-A6DD0791-4CED-42D7-9722-1FACAF91809BQ21105144-B77309F7-EC7D-4409-A731-5E20BED292F5Q21105148-4C148F8B-070A-4CD5-8F65-4635995670A3Q21105148-F453F2C5-3091-4FC5-8A83-063EEA07FCDEQ21108118-11819A79-23CF-403A-BD9F-72B8E3316685Q21110348-C6237539-38BC-4871-9BC9-47F766FA7E72Q21110348-C928A470-D300-4649-AB56-C1AC37474247Q21110352-0D1A4BCA-6599-435B-BA9C-22F411EDB3D3Q21110352-F1C3A68B-CB99-4DE0-9DEC-DBB8B9F84FC0Q21110358-94A91EAA-F098-4576-939D-43CBBDFA2E9BQ21110359-F07433DC-06A5-4F93-B48D-200999FCD057Q21111191-1A266DA4-5796-42A2-AD19-2B1341EA061DQ21111192-941BC495-88AA-4141-9191-5E4E0362699BQ21111193-615B679C-4900-420C-AD11-8258C727D97FQ21111195-7C4EE1E9-0B62-4451-B8D1-CF5E87EC3D44Q21111198-C95493B1-6431-4F0E-8B41-7464B8146540Q21111200-71E72FDA-5DBA-402F-8637-76F4B894CC8BQ21111201-5C51E62B-64F7-4E6D-B732-C8D1720D17F9Q21111202-FABE4474-DF15-4802-9034-96921960B23DQ21111211-CE68D823-FCF0-4559-B202-7BEB9E1EFD5CQ21111453-DD8BBFA3-EBE1-4786-84E5-9476B1F02D82Q21111453-F4FFBD8C-9B3A-4F88-80D3-190DF68FC702Q21119036-E2006D14-DBA1-460C-92F8-2755E5F3B49FQ21119037-E42C8145-82DD-4CD2-AE06-8ED4113F406CQ21133227-C9A33E10-8520-4822-9994-A5109EA6162EQ21433652-45F4628A-C9FD-4D2F-9007-330A617DAACEQ21433652-F6E2F935-BAEB-4032-9714-5752BEFDA2ABQ21433653-05ABA1E1-E3D5-48DE-86CA-0EECB7063E4AQ21433653-E04CC90B-F035-4932-BBED-7C48A9C28A3DQ21495333-0F93969F-9542-4626-96A3-858C8240489BQ21495334-3C237ED7-099E-4658-8BA1-196AD6B65017Q21495337-9EF81EDB-64A0-461B-84F0-390B76675334
P682
description
The chemical reactions and pat ...... MP, guanosine 3',5'-phosphate.
@en
biologisch proces
@nl
name
cGMP biosynthetic process
@en
type
label
cGMP biosynthetic process
@en
altLabel
GO:0006182
@en
cGMP anabolism
@en
cGMP biosynthesis
@en
cGMP formation
@en
cGMP synthesis
@en
prefLabel
cGMP biosynthetic process
@en
P279
P279
P2888
P686
GO:0006182